What You Should Know About A COVID-19 Vaccine
As the pandemic rolls on, researchers race to find answers ... En espa ñol | Researchers around the world have wasted no time in the race to find a vaccine to combat COVID-19. ... Six months into th... (Source: AARP.org News)
Source: AARP.org News - September 20, 2020 Category: American Health Source Type: news

Likely TIMELINE of events to take place from Sep. 20 to Jan. 20, covering vaccines, SCOTUS, Election Day, markets, terrorism and insurrection
(Natural News) What follows is a likely timeline of events to take place between now (Sep. 20, 2020) and Jan 20, 2021. Due to the extreme volatility of current events, almost no one dare make predictions these days, but this timeline is based on interviews with top law enforcement who have ties to federal agencies,... (Source: NaturalNews.com)
Source: NaturalNews.com - September 20, 2020 Category: Consumer Health News Source Type: news

AstraZeneca Releases Blueprints for Virus Vaccine Trial Amid Safety Scrutiny
A surge of infections in the Southwest and the Midwest is partly driving an uptick in cases nationally. The eight remaining members of the Supreme Court are expected to hear arguments next month via telephone. (Source: NYT Health)
Source: NYT Health - September 20, 2020 Category: Consumer Health News Tags: Coronavirus (2019-nCoV) Source Type: news

COVID-19 vaccine may not be generally available “until next summer”: CDC chief
(Natural News) The director of the Centers for Disease Control and Prevention (CDC), Dr. Robert Redfield, said on Sep. 16 that he believes a vaccine will be available for the American public around the second or third quarter of 2021. Redfield told lawmakers during a Senate Appropriations subcommittee hearing that any vaccine available by the... (Source: NaturalNews.com)
Source: NaturalNews.com - September 20, 2020 Category: Consumer Health News Source Type: news

Matt Hancock ’s Covid cavalry is not yet on the horizon. We need a global approach now
The UK has done well on building capacity. But only wide access to simple, effective tests will allow us to manage life under coronavirusCoronavirus – latest updatesSee all our coronavirus coverageAs the UK battles with the overwhelming demand for Covid-19 tests, the health secretary, Matt Hancock, said on Friday that the country needs to come together to keep the infection levels downwhile we await the cavalry on the horizon.The cavalry, he said, would come in the shape of the science that will bring a vaccine, effective treatments and the ability to undertake mass testing. Detecting cases, tracking contacts and con...
Source: Guardian Unlimited Science - September 20, 2020 Category: Science Authors: Trudie Lang Tags: Coronavirus outbreak Health World Health Organization Infectious diseases Medical research Microbiology Society Science World news Source Type: news

In ‘Power Grab,’ Health Secretary Azar Asserts Authority Over F.D.A.
Experts said the memo would make it more difficult for the F.D.A. to issue new rules, but it ’s unclear how it would affect the vetting of coronavirus vaccines. (Source: NYT Health)
Source: NYT Health - September 20, 2020 Category: Consumer Health News Authors: Sheila Kaplan Tags: Coronavirus (2019-nCoV) Regulation and Deregulation of Industry United States Politics and Government Food and Drug Administration Centers for Medicare and Medicaid Services Centers for Disease Control and Prevention Source Type: news

AstraZeneca, Under Fire for Vaccine Safety, Releases Trial Blueprints
Experts are concerned that the company has not been more forthcoming about two participants who became seriously ill after getting its experimental vaccine. (Source: NYT Health)
Source: NYT Health - September 20, 2020 Category: Consumer Health News Authors: Denise Grady, Katherine J. Wu and Sharon LaFraniere Tags: Clinical Trials Vaccination and Immunization Coronavirus (2019-nCoV) Drugs (Pharmaceuticals) AstraZeneca PLC Source Type: news

AstraZeneca, under fire for coronavirus vaccine safety, releases trial blueprints
Polls are finding Americans increasingly wary of accepting a coronavirus vaccine. And scientists inside and outside the government are worried that regulators, pressured by the president for results before Election Day on Nov. 3, might release an unproven or unsafe vaccine. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 20, 2020 Category: Pharmaceuticals Source Type: news

Electronic Vaccine Intelligence Network to track COVID-19 vaccine
A national expert group on COVID-19 vaccine has been constituted to guide the government on prioritisation of population groups for vaccination, selection of vaccine candidates, delivery mechanism of the vaccine, cold chain and associated infrastructure for roll-out of COVID-19 vaccination, etc. Minister of State for Health Ashwini Kumar Choubey said. (Source: The Economic Times)
Source: The Economic Times - September 20, 2020 Category: Consumer Health News Source Type: news

Three vaccine candidates in different stages of clinical trial: Harsh Vardhan
Replying to a discussion in Lok Sabha on the coronavirus pandemic, the Health Minister said there are 13,000 quarantine centres in the country with over 6 lakh beds. (Source: The Economic Times)
Source: The Economic Times - September 20, 2020 Category: Consumer Health News Source Type: news

The coronavirus vaccine volunteer: 'I hope this is a kick up the ass to do things better'
Both benevolence and selfishness inspired Josh McGrane to take part in the University of Oxford vaccine trialsCoronavirus – latest updatesSee all our coronavirus coverageThe world is watching the Covid-19 vaccine trials conducted by the University of Oxford ’sJenner Institute closely. AustralianJosh McGrane is an associate professor and educational researcher living in Oxford. He decided to take part in the trials when he saw the call-out for volunteers on Facebook earlier this year.Why did you get involved?It was a mix of selfishness and benevolence. This was in March, everything was kicking off in the UK and ...
Source: Guardian Unlimited Science - September 19, 2020 Category: Science Authors: As told to Alexandra Spring Tags: Vaccines and immunisation Coronavirus outbreak Australia news University of Oxford Australian media Science Health Source Type: news

Democrats face quandary on vaccine support as election nears
President Trump escalates promise for a coronavirus vaccine before Election Day. (Source: ABC News: Health)
Source: ABC News: Health - September 19, 2020 Category: Consumer Health News Tags: Health Source Type: news

The Latest: Pope urges vaccine access to poorest nations
Pope Francis is urging political leaders make sure coronavirus vaccines are available to the poorest nations (Source: ABC News: Health)
Source: ABC News: Health - September 19, 2020 Category: Consumer Health News Tags: Health Source Type: news

After Criticism, C.D.C. Reverses Covid-19 Guidelines on Testing People Who Were Exposed
President Trump acknowledged that an authorized vaccine for “every American” may not be distributed until next year. An Iranian official says the country has become a “red zone” as cases and deaths surge. (Source: NYT Health)
Source: NYT Health - September 19, 2020 Category: Consumer Health News Tags: Coronavirus (2019-nCoV) Source Type: news

Africa: Accessibility of Vaccines & Commitment to Ceasefire - Priority Focuses for 75th UNGA
[IPS] United Nations -- Key focuses of the upcoming 75th session of the United Nations General Assembly (UNGA) High Level Week will be the accessibility of vaccines and a renewed plea for a global ceasefire. "I will make a strong appeal to the international community to mobilise all efforts for the global ceasefire to become a reality by the end of the year," U.N. Secretary-General Ant ónio Guterres said on Wednesday. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - September 19, 2020 Category: African Health Source Type: news

Medical experts v anti-vaxxers: the Covid-19 information battle
Scientists face potential struggle to convince people of vaccine safety as celebrities join misinformation chorusFull report: engagement with anti-vaccine Facebook posts treblesCoronavirus – latest updatesSee all our coronavirus coverageOn one side is the “anti-vax” movement, a constellation of groupings drawn from across the ideological spectrum, far-right opportunists and celebrities including the former Stone Roses frontman Ian Brown.On the other is the NHS, virtually the entire medical community, government departments and Brown ’s former Stone Roses bandmate John Squire.Continue reading... (Sou...
Source: Guardian Unlimited Science - September 19, 2020 Category: Science Authors: Ben Quinn and Niamh McIntyre Tags: Coronavirus outbreak Vaccines and immunisation Ian Brown Van Morrison Music Culture Media Social media Twitter Facebook Digital media Social networking Technology UK news NHS Science Infectious diseases Health Society Source Type: news

Coronavirus live news: Trump pledges vaccine for all by April as Melbourne faces more protests
Number of cases worldwide passes 30 million; Victoria announces 21 new Covid-19 cases and seven more deaths; UK faces possible second national lockdown. Follow all the developmentsMutant virus: should we be worried that Sars-CoV-2 is changing ?UK entering second wave of virus, Johnson warns‘Shocking’: Trump under fire from ex-adviser for Covid failures5.31amBSTThe Victorian Department of Health and Human Services has put out some more information on the latest case numbers today.The 21 cases is the lowest number of new cases since 24 June.Of the 834 current active cases in Victoria:5.12amBSTThe Australian minis...
Source: Guardian Unlimited Science - September 19, 2020 Category: Science Authors: Josh Taylor (now) and Lisa Cox (earlier) Tags: Coronavirus outbreak Infectious diseases Science World news Source Type: news

Trump’s April vaccine forecast puts him at odds with experts
US president’s prediction comes as CDC reverses course on testing guidelines (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - September 19, 2020 Category: Pharmaceuticals Source Type: news

Live Covid-19 Tracker and Updates
President Trump acknowledged that an authorized vaccine for ‘every American’ may not be distributed until next year. An Iranian official says the country has become a “red zone” as cases and deaths surge. (Source: NYT Health)
Source: NYT Health - September 19, 2020 Category: Consumer Health News Tags: Coronavirus (2019-nCoV) Source Type: news

Is it covid-19 or the flu? What doctors say about the symptoms.
The viruses' symptoms are similar, making it hard to distinguish between them. Doctors are urging people to get the annual flu vaccine to prevent a "twindemic" this fall and winter. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - September 19, 2020 Category: Consumer Health News Authors: Marisa Iati Source Type: news

Making a Covid vaccine is tough. So is shipping one at -80 degree Arctic temperatures
A number of the leading COVID-19 vaccines under development will need to be kept at temperatures as low as minus 80 degrees Celsius (minus 112 degrees Fahrenheit) from the moment they are bottled to the time they are ready to be injected into patients ’ arms. That will not be easy. (Source: The Economic Times)
Source: The Economic Times - September 19, 2020 Category: Consumer Health News Source Type: news

Where are we with coronavirus vaccines? Here are the promising nine
There were several developments regarding vaccines and drugs this week, including the tie-up between the makers of Russia ’s Sputnik V vaccine and Dr Reddy’s. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 19, 2020 Category: Pharmaceuticals Source Type: news

E-certificates for people getting coronavirus vaccinations, says senior official
A government expert group on vaccines, which is looking into the procurement of Covid-19 vaccines — made in India and abroad — and the guiding principles for prioritisation of population groups for vaccination, has proposed setting up a digital platform to track procurement and record administration. (Source: The Economic Times)
Source: The Economic Times - September 19, 2020 Category: Consumer Health News Source Type: news

Phase-III trial of Oxford vaccine to begin in Pune next week
The SII has partnered with British-Swedish pharma company AstraZeneca for manufacturing the COVID-19 vaccine candidate, developed by the University of Oxford. (Source: The Economic Times)
Source: The Economic Times - September 19, 2020 Category: Consumer Health News Source Type: news

Push is underway to test COVID-19 vaccines in diverse groups
Companies are struggling to recruit diverse volunteers in final U.S. tests of possible COVID-19 vaccines (Source: ABC News: Health)
Source: ABC News: Health - September 18, 2020 Category: Consumer Health News Tags: Health Source Type: news

Trump Now Claims 'Every American' Will Have Coronavirus Vaccine By April
The president has contradicted health experts, and now his own ambitious timeline, for a vaccine against COVID-19.(Image credit: Alex Wong/Getty Images) (Source: NPR Health and Science)
Source: NPR Health and Science - September 18, 2020 Category: Consumer Health News Authors: Alana Wise Source Type: news

Sanofi and GSK will provide up to 300 million doses of COVID-19 vaccine to the European Union
Sanofi and GSK finalized and signed today an Advanced purchase agreement with the European Commission (EC) for the supply of up to 300 million doses of a COVID-19 vaccine, once the vaccine is approved. The vaccine candidate is based on the recombinant protein-based technology used by Sanofi to produce an influenza vaccine, and GSK's established adjuvant technology. (Source: World Pharma News)
Source: World Pharma News - September 18, 2020 Category: Pharmaceuticals Tags: Featured Sanofi Business and Industry Source Type: news

How to Ship a Vaccine at –80°C, and Other Obstacles in the Covid Fight
Developing an effective vaccine is the first step. Then comes the question of how to deliver hundreds of millions of doses that may need to be kept at arctic temperatures. (Source: NYT Health)
Source: NYT Health - September 18, 2020 Category: Consumer Health News Authors: David Gelles Tags: Vaccination and Immunization Coronavirus (2019-nCoV) Ice Shortages Carbon Dioxide AstraZeneca PLC BioNTech SE Centers for Disease Control and Prevention Corning Inc Fedex Corporation Moderna Inc Pfizer Inc United Parcel Service Inc Source Type: news

Details Emerge on Unexplained Illness in AstraZeneca COVID - 19 Vaccine Trial
Healthy 37 - year - old woman'experienced confirmed transverse myelitis'after receiving second dose of vaccine (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - September 18, 2020 Category: Respiratory Medicine Tags: Family Medicine, Gynecology, Infections, Internal Medicine, Critical Care, Emergency Medicine, Neurology, Nursing, Pharmacy, Pulmonology, Institutional, Source Type: news

We Need a COVID-19 Vaccine. We Also Need Transparency About Its Development
The authorization of an effective vaccine will mark perhaps the biggest turning point in the battle against coronavirus, but only if enough people are willing to get vaccinated. There have been substantial declines in public willingness to get vaccinated against COVID-19, despite immense, unprecedented public investments in vaccine development. In one survey, barely half of Americans said they would get the vaccine as soon as it was available, numbers that will undermine the benefits of even a highly effective vaccine. It is no mystery why trust in a potential vaccine has plummeted. Operation Warp Speed, the Trump Administ...
Source: TIME: Health - September 18, 2020 Category: Consumer Health News Authors: Dr. Ashish K. Jha Tags: Uncategorized COVID-19 Source Type: news

Moderna: We'll Know Soon if COVID Vaccine Works
Along with Moderna's vaccine, there are six others in final Phase 3 testing that involves large-scale human tests. (Source: WebMD Health)
Source: WebMD Health - September 18, 2020 Category: Consumer Health News Source Type: news

Stocks Will Take A Hit From Second Wave Of Coronavirus, Wall Street Firm Warns Clients
“We’re not getting out of this without a vaccine,” Bernstein said. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 18, 2020 Category: Pharmaceuticals Authors: Sergei Klebnikov, Forbes Staff Tags: Markets /markets Money /money Business /business Innovation /innovation Science /science Healthcare /healthcare ETFs & Mutual Funds /etfs-mutual-funds Hedge Funds Private Equity /hedge-funds-private-equity Investing Source Type: news

Pfizer Vaccine Trial Bets on Early Win Against Coronavirus, Documents Show Pfizer Vaccine Trial Bets on Early Win Against Coronavirus, Documents Show
Pfizer is betting that its coronavirus vaccine candidate will show clear evidence of effectiveness early in its clinical trial, according to the company and internal documents reviewed by Reuters that describe how the trial is being run.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 18, 2020 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

France Won't Buy Vaccines Through WHO's COVAX Scheme: Ministry Source France Won't Buy Vaccines Through WHO's COVAX Scheme: Ministry Source
France will provide funding for an initiative led by the World Health Organization to buy potential COVID-19 vaccines, but will not source shots through the programme.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 18, 2020 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Latin American Nations Seek More Time to Join WHO Vaccine Plan Latin American Nations Seek More Time to Join WHO Vaccine Plan
Several Latin American countries have informed the World Health Organization (WHO) they intend to request more time to sign up for its global COVID-19 vaccine allocation plan known as COVAX.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 18, 2020 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Moderna to Seek Limited Emergency Use of COVID-19 Vaccine if Data Shows High Efficacy Moderna to Seek Limited Emergency Use of COVID-19 Vaccine if Data Shows High Efficacy
If Moderna Inc's COVID-19 vaccine proves to be at least 70% effective, the company plans to seek emergency authorization for its use in high-risk groups, the company's chief executive told Reuters.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 18, 2020 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Details Emerge on Unexplained Illness in AstraZeneca COVID-19 Vaccine Trial
FRIDAY, Sept. 18, 2020 -- New details surfaced on Thursday on an unexplained neurological condition that struck a volunteer who was participating in AstraZeneca's COVID-19 vaccine trial. In an internal safety report obtained by CNN, company... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 18, 2020 Category: Pharmaceuticals Source Type: news

Thousands of people have joined Brighteon.social to exercise free speech about vaccines, Christianity, Trump and other topics that get banned by Big Tech
(Natural News) Since launching the beta version of Brighteon.social, the new social media alternative to Twitter, thousands of people have joined the network and are expressing all sorts of positive comments about being able to speak without censorship. Brighteon.social allows you to post memes, short text messages, pictures and short videos. (For longer videos, post... (Source: NaturalNews.com)
Source: NaturalNews.com - September 18, 2020 Category: Consumer Health News Source Type: news

Covid-19: Do many people have pre-existing immunity?, BMJ
BMJ Feature explores the emerging research on immunological responses, concluding that without further research, it is unknown whether pre-existing immunity could be more protective than future vaccines. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - September 18, 2020 Category: Consumer Health News Source Type: news

The Association of Pharmacy Technicians UK (APTUK) issues guidance on pharmacy technicians administering vaccines
The Association of Pharmacy Technicians UK (APTUK) has issued new professional guidance around the administration of vaccines. This encourages pharmacy technicians to ensure all legal frameworks, regu (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - September 18, 2020 Category: Drugs & Pharmacology Source Type: news

Mutant virus: should we be worried that Sars-CoV-2 is changing?
Scientists tracking the virus have uncovered a major mutation, but it may not be as scary as it soundsCoronavirus – latest updatesSee all our coronavirus coverageScientists have had eyes on Sars-CoV-2, the virus that causes Covid-19, since the beginning of this pandemic.They can see it is evolving, but it is happening at a glacial pace compared with two other viruses with pandemic potential: those that cause flu and Aids. That is good news for efforts to develop vaccines and treatments, but scientists remain wary that anything could still happen.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - September 18, 2020 Category: Science Authors: Laura Spinney Tags: Coronavirus outbreak Infectious diseases Medical research Microbiology Science World news Vaccines and immunisation Health Source Type: news

CDC director says face masks “more guaranteed” to protect against coronavirus than any vaccine
(Natural News) Dr. Robert Redfield, director of the Centers for Disease Control and Prevention (CDC), said in a Sep. 16 Senate hearing that using face masks is “more guaranteed” to protect against the coronavirus than getting the COVID-19 vaccine. Redfield exhorted Americans during the hearing to not dismiss the effectiveness of wearing a mask. Redfield... (Source: NaturalNews.com)
Source: NaturalNews.com - September 18, 2020 Category: Consumer Health News Source Type: news

Yes, Fauci and Gates do have ties to COVID-19 vaccine maker
(Natural News) n September 11, USA Today published an article with a headline declaring, “Fact check: Fauci, Gates, Epstein and Soros have no ties to drug company Moderna”. (Article republished from JeremyRHammond.com) But that headline was false. Both Anthony Fauci, the director of the National Institute for Allergy and Infectious Disease (NIAID) and member of the White House... (Source: NaturalNews.com)
Source: NaturalNews.com - September 18, 2020 Category: Consumer Health News Source Type: news

Queensland to reopen border to ACT
NSW, WA and Qld to raise cap on international arrivals; Victoria reports 45 new cases and five deaths and NSW reports six cases; Queensland to reopen ACT border from 25 September. This blog is now closedFollow our global coronavirus live blogFlight caps fight looms at national cabinet as Morrison pledges pandemic health funding‘A moment of cheer’: 100-year-old Victorian man leaves hospital after surviving coronavirus fight‘I volunteered to be a human guinea pig for a Covid vaccine. Now I’m having second thoughts’10.03amBSTThat ’s it for our live coverage of the coronavirus and other big ...
Source: Guardian Unlimited Science - September 18, 2020 Category: Science Authors: Graham Readfearn (now), and Naaman Zhou and Calla Wahlquist (earlier) Tags: Australia news Coronavirus outbreak Scott Morrison New South Wales Infectious diseases Science Australian politics Victoria Queensland politics Source Type: news

Details Emerge on Unexplained Illness in AstraZeneca COVID Vaccine Trial
FRIDAY, Sept. 18, 2020 (Healthday News) -- New details surfaced on Thursday on an unexplained neurological condition that struck a volunteer who was participating in AstraZeneca's coronavirus vaccine trial. In an internal safety report obtained by... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 18, 2020 Category: General Medicine Source Type: news

South Africa: South Africa Resumes Oxford Covid-19 Vaccine Trial After Reassurance On Safety
[Daily Maverick] The SA Health Products Regulatory Authority and two ethics committees have given their approval for the resumption of the Oxford Covid-19 vaccine trial in South Africa. The trial was paused globally almost a week ago after an independent data and safety monitoring committee recommendation to review the case of an ill participant. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - September 18, 2020 Category: African Health Source Type: news

Coronavirus Vaccine: Moderna and Pfizer Reveal Secret Blueprints Trials
The companies hope to earn the trust of the public and of scientists who have clamored for details of the studies. (Source: NYT)
Source: NYT - September 18, 2020 Category: American Health Authors: Denise Grady and Katie Thomas Tags: Coronavirus (2019-nCoV) Vaccination and Immunization Clinical Trials Moderna Inc Source Type: news

Increased demand, efficacy among experts' flu vaccine concerns in COVID-19 era
Vaccine manufacturers have ramped up production of the 2020-21 flu shot during the COVID-19 pandemic, with the two viruses expected to overlap this winter, experts told UPI. (Source: Health News - UPI.com)
Source: Health News - UPI.com - September 18, 2020 Category: Consumer Health News Source Type: news

Roche launches new quantitative antibody test to measure SARS-CoV-2 antibodies, to support the evaluation of vaccines
Basel, 18 September 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of its Elecsys ® Anti-SARS-CoV-2 S antibody test for markets accepting the CE Mark. Roche has filed for Emergency Use Authorisation (EUA) from the U.S. Food and Drug Administration (FDA). The Elecsys Anti-SARS-CoV-2 serology test can be used to quantitatively measure antibodies in people who have been exposed to the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and can play an important part in characterising a vaccine-induced immune response.1 Specifically, the test targets antibodies which are directed against the ...
Source: Roche Media News - September 18, 2020 Category: Pharmaceuticals Source Type: news

Roche launches new quantitative antibody test to measure SARS-CoV-2 antibodies, to support the evaluation of vaccines
Basel, 18 September 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of its Elecsys ® Anti-SARS-CoV-2 S antibody test for markets accepting the CE Mark. Roche has filed for Emergency Use Authorisation (EUA) from the U.S. Food and Drug Administration (FDA). The Elecsys Anti-SARS-CoV-2 serology test can be used to quantitatively measure antibodies in people who have been exposed to the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and can play an important part in characterising a vaccine-induced immune response.1 Specifically, the test targets antibodies which are directed against the ...
Source: Roche Investor Update - September 18, 2020 Category: Pharmaceuticals Source Type: news